Ex-Div Reminder For MFS High Income Municipal Fund (CXE)

Looking at the universe of stocks we cover at Dividend Channel, on 6/18/13, MFS High Income Municipal Fund (CXE) will trade ex-dividend, for its monthly dividend of $0.027, payable on 6/28/13. As a percentage of CXE's recent stock price of $5.03, this dividend works out to approximately 0.54%, so look for shares of MFS High Income Municipal Fund to trade 0.54% lower — all else being equal — when CXE shares open for trading on 6/18/13.

START SLIDESHOW:
Click here to learn which 25 S.A.F.E. dividend stocks should be on your radar screen »

Below is a dividend history chart for CXE, showing historical dividends prior to the most recent $0.027 declared by MFS High Income Municipal Fund:

CXE+Dividend+History+Chart

In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from CXE is likely to continue, and whether the current estimated yield of 6.44% on annualized basis is a reasonable expectation of annual yield going forward.The chart below shows the one year performance of CXE shares, versus its 200 day moving average:

MFS High Income Municipal Fund 200 Day Moving Average Chart

Looking at the chart above, CXE's low point in its 52 week range is $4.82 per share, with $6.08 as the 52 week high point — that compares with a last trade of $4.99.

In Friday trading, MFS High Income Municipal Fund shares are currently up about 1.2% on the day.

null

More from Stocks

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

3 Great Stock Market Sectors Millennials Should Invest In

3 Great Stock Market Sectors Millennials Should Invest In

Why Millennials Are Ditching Stocks for ETFs

Why Millennials Are Ditching Stocks for ETFs

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says